• Skip to primary navigation
  • Skip to main content
  • Skip to footer
TREAT-NMD

TREAT-NMD

Advancing diagnosis, care and treatment for people with neuromuscular diseases around the world

Contact us

header-right

  • Home
  • Who We Are
    • About Us
    • Partnerships and Collaborations
    • Governance
    • Our Team
  • Who We Support
    • Patients
    • Clinicians / Researchers
    • Life Sciences Industry
  • What We Do
    • Advisory Committee for Therapeutics
    • The Global Registry Network
    • Core Datasets
    • Education
    • Post-Marketing Surveillance
  • Resources and Support
    • Neuromuscular Disease Information
    • Research Overview
    • Standards of Care & Family Guides
    • SOP Library
    • Social and Ethical Issues
  • Connect With Us
    • News
    • Events
    • Submit an Event
    • Newsletter Sign-up
    • Network Membership
    • Contact Us
Slide 1

Advancing Diagnosis,
Care & Treatment

...for those living with
Neuromuscular Diseases

Slide 2

We connect and inform

Slide 3

We accelerate change

We Accelerate Change...

TREAT-NMD is a global network of experts in the neuromuscular field. Everyone in our network helps us work towards our mission to accelerate the development of effective treatments; and establish the best in diagnosis and care for people worldwide.

Who We Support...

Patients
Clinicians / Researchers
Industry

What We Do...

Advisory Committee for Therapeutics

Evaluating the therapeutic potential of drugs to optimise their design and development. 

More Info

Global Registry Network

A federated network of 67 individual, independent, national (or regional) patient registries that collect data on neuromuscular patients from more than 61 countries worldwide. 

More Info

Education

Giving healthcare providers greater understanding of the diagnosis and management of neuromuscular diseases. 

More Info

Post-Marketing Surveillance

TREAT-NMD contributes to post-marketing surveillance in the neuromuscular field by acting as an independent partner of Life Sciences Industry and Clinical Research Organisations to facilitate and contribute to international, disease specific PMS systems and processes to fulfil regulatory requirements.

More Info

Resources and Support

Providing information to patients and health care providers to improve patients’ diagnosis and care. 

More Info

Connecting the Network

Bringing people together to accelerate cutting-edge therapies for otherwise unmet needs. 

More Info

TREAT-NMD Latest News...

SAVE THE DATE for the 8th TREAT-NMD International Conference!

We are very pleased to announce that we now have the dates confirmed for the next TREAT-NMD International conference! The conference will take place from the 6th-8th February 2025 in […]

TREAT-NMD Alliance Ltd. Introduces Updated Governance Structure

In a notable development, TREAT-NMD Alliance Ltd., a registered charity, has introduced a revised governance framework. This update also includes TREAT-NMD Service Ltd., its wholly owned business arm. The changes […]

Virtual TREAT-NMD Advisory Committee for Therapeutics meeting held online

The second virtual meeting of the year for the TREAT-NMD Advisory Committee for Therapeutics (TACT) occurred on September 29th to review a programme in Duchenne muscular dystrophy. TACT is composed […]

Application Process Closing Soon for the Expert Becker Muscular Dystrophy Masterclass, Barcelona 2023

Our new education initiative in Becker muscular dystrophy has proven very popular, but there is still time to apply!  The application process will be closing on Monday 9th October so, […]

Early Diagnosis for Duchenne Muscular Dystrophy Project

Early diagnosis for Duchenne muscular dystrophy presents its own challenges in terms of both the clinical and psychosocial sphere.  In July, TREAT-NMD hosted a discussion led by Michelle Lorentzos (Paediatric […]

Twenty free e-learning courses for healthcare professionals now available on the TREAT-NMD Talent Learning Management System (LMS)

In the ever-evolving field of healthcare, continuous learning is not just a choice; it’s a necessity. Staying up-to-date with the latest developments, best practices, and advancements in your specialty is […]

Raising Awareness in September

September marked a significant month for muscular dystrophy awareness with three important awareness days: World Duchenne Day on September 7th, Myotonic Dystrophy Awareness Day on the 15th, and Limb Girdle […]

TREAT-NMD’s Presence at World Muscle Society and Orphan Drug Congresses

October is abuzz with exciting events, including the 28th International Annual Congress of the World Muscle Society (WMS) and the World Orphan Drug Congress. WMS is scheduled from October 3rd– […]

Footer

Contact us

4th Floor
The Catalyst
Newcastle upon Tyne
NE4 5TG
United Kingdom
info@treat-nmd.com

Links

Home
Who we are
What we do
Who we support
Resources & support
Connect with us
Privacy Policy
Cookies

Newsletter sign up

Connect

info@treat-nmd.com
TREAT NMD © 2023
Privacy Policy
Sitemap
STCS LTD

  • Home
  • Who We Are
    • About Us
    • Partnerships and Collaborations
    • Governance
    • Our Team
    • Back
  • Who We Support
    • Patients
    • Clinicians / Researchers
    • Life Sciences Industry
    • Back
  • What We Do
    • Advisory Committee for Therapeutics
      • Members of the Advisory Committee for Therapeutics
      • Take Part in TACT
      • The Report
      • Back
    • The Global Registry Network
      • Members of the Registry Network
      • Back
    • Core Datasets
      • DM dataset
      • DMD dataset
      • FSHD dataset
      • LGMD
      • SMA
      • Back
    • Education
      • Masterclasses
      • E-learning Platform
      • Endorsement of External Programmes
      • Back
    • Post-Marketing Surveillance
    • Back
  • Resources and Support
    • Neuromuscular Disease Information
      • Becker muscular dystrophy
      • Charcot-Marie-Tooth
      • Congenital muscular dystrophy
      • Congenital myasthenic syndromes
      • Duchenne muscular dystrophy
      • Facioscapulohumeral muscular dystrophy
      • GNE myopathy
      • Limb girdle muscular dystrophy
      • Myotonic dystrophy
      • Myotubular and centronuclear myopathies
      • Spinal muscular atrophy
      • Back
    • Research Overview
      • DMD
        • Gene Therapy for DMD
        • Mutation Specific Approaches
        • Cell Therapy
        • Drug Therapy
        • Back
      • Back
    • Standards of Care & Family Guides
      • CM Care
      • CMD Care
      • DM Care
      • DMD Care
      • FSHD Care
      • SMA Care
      • Back
    • SOP Library
      • MDX Mouse (DMD)
      • GRMD Dog (DMD)
      • CMD Mouse (CMD)
      • SMA Mouse (SMA)
      • CMD animal models
      • MDC1A Preclinical Research
      • Cell Lines
        • Clinical Outcome Measures
        • Functional Evaluation Tools
        • NMR (MRI/MRS) Imaging
        • Muscle Biopsy
        • Back
      • Back
    • Social and Ethical Issues
    • Back
  • Connect With Us
    • News
    • Events
    • Submit an Event
    • Newsletter Sign-up
    • Network Membership
    • Contact Us
    • Back